Chlamydia is a sexually transmitted infection where the patient experiences no symptoms and can be contracted by both men and women (Uphold & Graham, 2013). The most commonly used test for diagnosing Chlamydia infection is the Nucleic Acidic Amplification Test (NAAT) that can detect bacterium or in body tissues and fluids such as urine. Chlamydia is tested by testing the urine in men and to swab women’s vagina (Uphold & Graham, 2013). People with Chlamydia are treated with oral antibiotics such as Azithromycin and Doxycycline (Uphold & Graham, 2013). Azithromycin is an effective pharmacological intervention for Chlamydia as it administered once and inexpensive making it easy for the patients to adhere to the treatment.
Uphold & Graham (2013) notes that there is a high chance of comorbidity of Chlamydia and gonorrhea and heterosexual patients. Just like Chlamydia, NAAT can also be used to diagnose Neisseria Gonorrhea. There are no visible symptoms of gonorrhea in infected women, but advancement in the condition can lead to pelvic inflammatory disease (PID). According to Uphold & Graham (2013), issues such as chronic pelvic pain, ectopic pregnancy and infertility can arise if pelvic inflammatory disease is left untreated. Some of the symptoms of PID include cervical excitation, vaginal discharge and a burning sensation when urinating (Miller, 2006). Bacterium Neisseria gonorrhoeae can prevent antibiotics from working leading to ineffective standard treatments. Due to the antimicrobial resistance, CDC treatment guidelines recommend the use of Ceftriaxone (Rocephin), 250 mg intramuscularly together with other oral antibiotics such as Azithromycin (Uphold & Graham, 2013).
Counseling the patient and providing them with the necessary information is essential in improving the quality of care and patient decision making but for effectiveness, the care giver needs to exude empathy and respect (Uphold & Graham). The care giver should educate their patients on preventive measures such as the use of condoms that can protect them from contracting sexually transmitted infections such as Chlamydia and gonorrhea. A care plan should be developed to deal with all the necessary factors that will ensure the patient adheres to preventive and curative interventions. The patient should be made aware of abstaining from sexual intercourse after single-dose administration of medication and his/her sexual partner(s) in the past 60 days need to be informed for better care (Uphold & Graham, 2013). Informing and treating the patient’s sexual partners helps reduce cases of reinfection. Expedited Partner Therapy, which involves giving the Chlamydia or gonorrhea patients prescriptions to take to their sexual partners, is not recommendable as the other partners need further examination and also counseling by a medical officer. Uphold & Graham (2013) noted that Chlymadia and gonorrhea patient need to be monitored regularly and retested as regular as within three months to avoid reinfection by untreated partners.